PATENT CLAIM ANALYSIS

Application Number: 16309080
Application Type: Utility
Filing Date: 2018-12
Publication Date: 2019-04
Patent Classification: ["514", "210160"]

Abstract:
Fused aromatic bicyclic substituted 5-(2-amino-4-pyrimidinyl)-cyanoindoline derivatives (I) useful for therapy and/or prophylaxis in a mammal, and in particular to inhibitors of NF-KB-inducing kinase (NIK—also known as MAP3K14) useful for treating diseases such as cancer, inflammatory disorders, metabolic disorders and autoimmune disorders. The invention is also directed to pharmaceutical compositions comprising such compounds, and to the use of such compounds or pharmaceutical compositions for the prevention or treatment of diseases such as cancer, inflammatory disorders, metabolic disorders including obesity and diabetes, and autoimmune disorders.

Claim (Index 9):
The compound according to  claim 8 , wherein\n R 3  represents a fused bicyclic ring system selected from the following structures:

Metadata:
- Claim Count in Document: 50.0
- Percentile: 98.0
- Lexical Diversity: 1.75439
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15024603', '15766887', '15520342', '15755475', '13321158']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7733040969708946
- 35 USC 102 Novelty (BERT): 0.5402714634740874
- Combined Prediction Score: 0.7500008336212138
- Mean Citation Score: 341.545594
- Max Citation Score: 364.57202
- Similarity Product: 300.0800665001452

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test